Fundz

Who to call at Foresee Pharmaceuticals, and when

Fundz watches for the moments Foresee Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Foresee Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Foresee Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Foresee Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Foresee Pharmaceuticals signs global licensing agreement with Primevera Therapeutics for MMP-12 inhibitors.

Jan 08, 2026

Contract Type

agreement

TaiwanBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Foresee Pharmaceuticals has announced an exclusive global licensing agreement with Primevera Therapeutics for its MMP-12 inhibitor programs. The agreement includes an upfront payment and potential milestones totaling up to 574.5 million USD, aiming to enhance Foresee's financial stability and operational focus.

Company Information

Company

Foresee Pharmaceuticals

Location

Taiwan

About

Foresee Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. The company specializes in drug discovery and advancing its pipeline of drug candidates. It aims to enhance shareholder value by forging strategic partnerships and optimizing its product portfolio.

Related People

Scott
Senior decision-maker at this company
••••••••@••••••••

See Scott's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Foresee Pharmaceuticals's next move

Learn about Strategic plan

Foresee Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.